Lista de obras -

A case of squamous cell carcinoma of the scalp after several synthetic hair grafts

artículo científico publicado en 2012

A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma ⬇️

artículo científico publicado el 1 de diciembre de 1992

A comparative study of the cutaneous side effects between BRAF monotherapy and BRAF/MEK inhibitor combination therapy in patients with advanced melanoma: a single-centre experience

artículo científico publicado en 2017

A gene expression signature associated with survival in metastatic melanoma

artículo científico publicado en 2006

A germline predictive signature of response to platinum chemotherapy in esophageal cancer

article

A pilot study of concomitant radiation and chemotherapy in patients with locally advanced head and neck cancer

scientific article published on 01 June 1993

A retrospective analysis of 141 patients with liver metastases from uveal melanoma: a two-cohort study comparing transarterial chemoembolization with CPT-11 charged microbeads and historical treatments.

artículo científico publicado en 2015

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.

artículo científico publicado en 2017

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

artículo científico publicado en 2017

Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial

scientific article published on 07 August 2019

Administration of anti-HER2 antibody after nonmyeloablative allogeneic stem cell transplantation in metastatic breast cancer.

artículo científico publicado en 2006

An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system

artículo científico publicado en 2018

Anetoderma in cutaneous marginal-zone B-cell lymphoma

artículo científico publicado en 2009

BRAF gene copy number and mutant allele frequency correlate with time to progression in metastatic melanoma patients treated with MAPK inhibitors.

artículo científico publicado en 2018

Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma.

artículo científico publicado en 2006

Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients.

artículo científico publicado en 2008

CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.

artículo científico publicado en 2017

Cholecystectomy during esophagectomy is safe but unnecessary

scientific article published on 08 January 2019

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.

artículo científico publicado en 2004

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.

artículo científico publicado en 2013

Clinical implication of tumor-associated and immunological parameters in melanoma patients treated with ipilimumab.

artículo científico publicado en 2016

Clonal heterogeneity of melanoma in a paradigmatic case study: future prospects for circulating melanoma cells

artículo científico publicado en 2019

Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, o

article

Complete Clinical Response After Neoadjuvant Chemoradiotherapy for Squamous Cell Cancer of the Thoracic Oesophagus: Is Surgery Always Necessary?

article

Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib.

artículo científico publicado en 2015

Contribution of susceptibility gene variants to melanoma risk in families from the Veneto region of Italy

article

Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced Melanoma

artículo científico publicado en 2018

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

artículo científico publicado en 2012

Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial.

artículo científico publicado en 2017

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

artículo científico publicado en 2017

Development and external validation of a prognostic nomogram for metastatic uveal melanoma

artículo científico publicado en 2015

Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanoma.

artículo científico publicado en 2013

Diagnostic services for melanoma in Italy.

artículo científico publicado en 2013

Effectiveness of dabrafenib in the treatment of patients with BRAF V600-mutated metastatic melanoma in a Named Patient Program

scientific article published on 01 October 2019

Effects of Neoadjuvant Therapy on Perioperative Morbidity in Elderly Patients Undergoing Esophagectomy for Esophageal Cancer

artículo científico publicado en 2007

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

artículo científico publicado en 2013

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme

artículo científico publicado en 2014

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

artículo científico publicado en 2014

Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma

artículo científico publicado en 2013

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study.

artículo científico publicado en 2010

Electrochemotherapy for disseminated superficial metastases from malignant melanoma

artículo científico publicado en 2012

Extramedullary plasmacytoma: Clinical behaviour and response to treatment ⬇️

artículo científico publicado el 1 de enero de 1992

First-Line Chemotherapy Improves the Resection Rate and Long-Term Survival of Locally Advanced (T4, any N, M0) Squamous Cell Carcinoma of the Thoracic Esophagus

artículo científico publicado en 1997

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

artículo científico publicado en 2020

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.

artículo científico publicado en 2019

Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial

artículo científico publicado en 2015

Follow-up of melanoma: a survey of Italian hospitals.

artículo científico publicado en 2013

Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation.

artículo científico publicado en 2009

Genetic features of metachronous esophageal cancer developed in Hodgkin's lymphoma or breast cancer long-term survivors: an exploratory study

artículo científico publicado en 2015

Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study

artículo científico publicado en 2015

Health-related quality of life results from the phase III CheckMate 067 study.

artículo científico publicado en 2017

IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.

artículo científico publicado en 2009

Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: A network meta-analysis.

artículo científico publicado en 2017

Impact of BRAF mutation and BRAF inhibition on melanoma brain metastases

artículo científico publicado en 2015

Impact of mole mapping in the Italian health system

artículo científico publicado en 2013

Interferon alpha for the adjuvant treatment of cutaneous melanoma

artículo científico publicado en 2013

Interferon alpha for the adjuvant treatment of melanoma: review of international literature and practical recommendations from an expert panel on the use of interferon

artículo científico publicado en 2013

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.

artículo científico publicado en 2011

Ipilimumab in real-world clinical practice: efficacy and safety data from a multicenter observational study.

artículo científico publicado en 2017

Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy

artículo científico publicado en 2014

Late relapses in Hodgkin's disease: Outcome of patients relapsing more than twelve months after primary chemotherapy ⬇️

artículo científico publicado el 1 de septiembre de 1993

Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III Melanoma

article

Management of small and intermediate congenital nevi: a nationwide survey in Italy.

artículo científico publicado en 2013

Melanoma Task Force (META) Project in Italy: methodology.

artículo científico publicado en 2013

Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer.

artículo científico publicado en 2008

Nivolumab in previously untreated melanoma without BRAF mutation

artículo científico publicado en 2015

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

artículo científico publicado en 2018

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAFV600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis.

artículo científico publicado en 2017

Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in Italy.

artículo científico publicado en 2018

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

artículo científico publicado en 2017

Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial

artículo científico publicado en 2018

Overdose of Vinblastine in place of Vinorelbine during IGEV chemotherapy

artículo científico publicado en 2012

PD-L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus

scientific article published on 20 August 2019

Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma

artículo científico publicado en 2013

Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine

artículo científico

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial

scientific article published on 27 March 2019

Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab.

artículo científico publicado en 2015

Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients.

artículo científico publicado en 2001

Phase II trial of interferon-?-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma

artículo científico publicado en 2002

Pre-operative chemoradiotherapy in non-small cell lung cancer stage III patients. Feasibility, toxicity and long-term results of a phase II study.

artículo científico publicado en 1996

Primary mediastinal large B-cell lymphoma: results of intensive chemotherapy regimens (MACOP-B/VACOP-B) plus involved field radiotherapy on 53 patients. A single institution experience

artículo científico publicado en 2007

Radiotherapy Alone in the Treatment of Clinical Stage I-IIA, Nonbulky, Hodgkin’s Disease

artículo científico publicado en 2002

Reply to E. Hindié and K.R. Hess

artículo científico publicado en 2019

Report from the Melanoma Independent Board First Melanoma MIB Conference, 21-22 October 2013.

artículo científico publicado en 2014

Reversible, PET-positive, generalized lymphadenopathy and splenomegaly during high-dose interferon-alpha-2b adjuvant therapy for melanoma.

artículo científico publicado en 2008

S quamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity

artículo científico publicado en 2019

Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172)

scientific article published on 30 September 2019

Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)

scientific article published on 21 August 2019

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program

artículo científico publicado en 2014

Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade.

artículo científico publicado en 2018

Small molecules and targeted therapies in distant metastatic disease.

scientific article published on August 2009

Surgery and radiotherapy in the treatment of cutaneous melanoma

artículo científico publicado en 2009

Surgical management of suspicious melanocytic lesions in Italy

artículo científico publicado en 2013

Surgical treatment of melanoma: a survey of Italian hospitals.

artículo científico publicado en 2013

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial

scientific article published on 01 February 2019

Systemic treatments for metastatic cutaneous melanoma

artículo científico publicado en 2018

TNF-Based Isolated Limb Perfusion Followed by Consolidation Biotherapy with Systemic Low-dose Interferon Alpha 2b in Patients with In-transit Melanoma Metastases: A Pilot Trial

scientific article published on 05 February 2008

Time to diagnosis in esophageal cancer: a cohort study.

artículo científico publicado en 2018

Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874]

artículo científico publicado en 2006

Treatment of chemotherapy-induced oral mucositis with light-emitting diode.

artículo científico publicado en 2006

Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.

artículo científico publicado en 2014

Lista de obras de

A case of squamous cell carcinoma of the scalp after several synthetic hair grafts

A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma ⬇️

A comparative study of the cutaneous side effects between BRAF monotherapy and BRAF/MEK inhibitor combination therapy in patients with advanced melanoma: a single-centre experience

A gene expression signature associated with survival in metastatic melanoma

A germline predictive signature of response to platinum chemotherapy in esophageal cancer

A pilot study of concomitant radiation and chemotherapy in patients with locally advanced head and neck cancer

A retrospective analysis of 141 patients with liver metastases from uveal melanoma: a two-cohort study comparing transarterial chemoembolization with CPT-11 charged microbeads and historical treatments.

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial

Administration of anti-HER2 antibody after nonmyeloablative allogeneic stem cell transplantation in metastatic breast cancer.

An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system

Anetoderma in cutaneous marginal-zone B-cell lymphoma

BRAF gene copy number and mutant allele frequency correlate with time to progression in metastatic melanoma patients treated with MAPK inhibitors.

Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma.

Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients.

CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.

Cholecystectomy during esophagectomy is safe but unnecessary

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.

Clinical implication of tumor-associated and immunological parameters in melanoma patients treated with ipilimumab.

Clonal heterogeneity of melanoma in a paradigmatic case study: future prospects for circulating melanoma cells

Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, o

Complete Clinical Response After Neoadjuvant Chemoradiotherapy for Squamous Cell Cancer of the Thoracic Oesophagus: Is Surgery Always Necessary?

Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib.

Contribution of susceptibility gene variants to melanoma risk in families from the Veneto region of Italy

Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced Melanoma

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial.

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

Development and external validation of a prognostic nomogram for metastatic uveal melanoma

Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanoma.

Diagnostic services for melanoma in Italy.

Effectiveness of dabrafenib in the treatment of patients with BRAF V600-mutated metastatic melanoma in a Named Patient Program

Effects of Neoadjuvant Therapy on Perioperative Morbidity in Elderly Patients Undergoing Esophagectomy for Esophageal Cancer

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study.

Electrochemotherapy for disseminated superficial metastases from malignant melanoma

Extramedullary plasmacytoma: Clinical behaviour and response to treatment ⬇️

First-Line Chemotherapy Improves the Resection Rate and Long-Term Survival of Locally Advanced (T4, any N, M0) Squamous Cell Carcinoma of the Thoracic Esophagus

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.

Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial

Follow-up of melanoma: a survey of Italian hospitals.

Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation.

Genetic features of metachronous esophageal cancer developed in Hodgkin's lymphoma or breast cancer long-term survivors: an exploratory study

Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study

Health-related quality of life results from the phase III CheckMate 067 study.

IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.

Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: A network meta-analysis.

Impact of BRAF mutation and BRAF inhibition on melanoma brain metastases

Impact of mole mapping in the Italian health system

Interferon alpha for the adjuvant treatment of cutaneous melanoma

Interferon alpha for the adjuvant treatment of melanoma: review of international literature and practical recommendations from an expert panel on the use of interferon

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.

Ipilimumab in real-world clinical practice: efficacy and safety data from a multicenter observational study.

Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy

Late relapses in Hodgkin's disease: Outcome of patients relapsing more than twelve months after primary chemotherapy ⬇️

Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III Melanoma

Management of small and intermediate congenital nevi: a nationwide survey in Italy.

Melanoma Task Force (META) Project in Italy: methodology.

Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer.

Nivolumab in previously untreated melanoma without BRAF mutation

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAFV600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis.

Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in Italy.

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial

Overdose of Vinblastine in place of Vinorelbine during IGEV chemotherapy

PD-L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus

Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma

Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial

Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab.

Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients.

Phase II trial of interferon-?-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma